BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31322068)

  • 21. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
    Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
    Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factors (VEGFs) and stroke.
    Greenberg DA; Jin K
    Cell Mol Life Sci; 2013 May; 70(10):1753-61. PubMed ID: 23475070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model.
    Park K; Amano H; Ito Y; Kashiwagi S; Yamazaki Y; Takeda A; Shibuya M; Kitasato H; Majima M
    Biomed Pharmacother; 2016 Mar; 78():140-149. PubMed ID: 26898435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion.
    Babiak A; Schumm AM; Wangler C; Loukas M; Wu J; Dombrowski S; Matuschek C; Kotzerke J; Dehio C; Waltenberger J
    Cardiovasc Res; 2004 Mar; 61(4):789-95. PubMed ID: 14985076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.
    Dziobek K; Opławski M; Grabarek B; Zmarzły N; Kiełbasiński R; Leśniak E; Januszyk P; Januszyk K; Adwent I; Dąbruś D; Kieszkowski P; Kiełbasiński K; Kuś-Kierach A; Boroń D
    Curr Pharm Biotechnol; 2019; 20(9):727-732. PubMed ID: 31215376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression Profile of Endoglin in Different Grades of Endometrial Cancer.
    Opławski M; Dziobek K; Adwent I; Dąbruś D; Grabarek B; Zmarzły N; Plewka A; Boroń D
    Curr Pharm Biotechnol; 2018; 19(12):990-995. PubMed ID: 30479213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
    Iyer S; Scotney PD; Nash AD; Ravi Acharya K
    J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
    Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
    Histopathology; 2012 Sep; 61(3):350-64. PubMed ID: 22690749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration.
    Nishida Y; Yamada Y; Kanemaru H; Ohazama A; Maeda T; Seo K
    Biomed Res; 2018; 39(6):287-294. PubMed ID: 30531158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
    Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
    Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
    Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
    Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study.
    Edirisinghe ST; Weerasekera M; De Silva DK; Devmini MT; Pathmaperuma S; Wijesinghe GK; Nisansala T; Maddumage A; Huzaini H; Rich AM; De Silva H; Trudy M; Goonasinghe R; De Silva K; Yasawardena S
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):267-274. PubMed ID: 36708576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer.
    Nusrat O; Belotte J; Fletcher NM; Memaj I; Saed MG; Diamond MP; Saed GM
    Reprod Sci; 2016 Nov; 23(11):1484-1492. PubMed ID: 27122375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
    Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
    Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma.
    Boscolo E; Mulliken JB; Bischoff J
    Am J Pathol; 2011 Nov; 179(5):2266-77. PubMed ID: 21945324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.
    D'Haene N; Koopmansch C; Van Eycke YR; Hulet F; Allard J; Bouri S; Rorive S; Remmelink M; Decaestecker C; Maris C; Salmon I
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of vascular endothelial growth factor and its receptors in canine lymphoma.
    Wolfesberger B; Guija de Arespacohaga A; Willmann M; Gerner W; Miller I; Schwendenwein I; Kleiter M; Egerbacher M; Thalhammer JG; Muellauer L; Skalicky M; Walter I
    J Comp Pathol; 2007 Jul; 137(1):30-40. PubMed ID: 17467003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between VEGFR-2 receptor kinase domain-containing receptor (KDR) mRNA and angiotensin II receptor type 1 (AT1-R) mRNA in endometrial cancer.
    Piastowska-Ciesielska AW; Płuciennik E; Wójcik-Krowiranda K; Bieńkiewicz A; Nowakowska M; Pospiech K; Bednarek AK; Domińska K; Ochędalski T
    Cytokine; 2013 Feb; 61(2):639-44. PubMed ID: 23273598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.